LifeVantage (NASDAQ:LFVN – Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.700-0.800 for the period, compared to the consensus earnings per share estimate of 0.720. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $204.8 million.
LifeVantage Stock Down 0.4 %
LFVN traded down $0.05 during midday trading on Wednesday, hitting $12.93. 228,284 shares of the company traded hands, compared to its average volume of 60,322. The firm has a market capitalization of $164.22 million, a PE ratio of 46.18 and a beta of 0.84. The company’s 50-day moving average is $10.77 and its 200 day moving average is $8.31. LifeVantage has a 52 week low of $4.20 and a 52 week high of $14.71.
LifeVantage (NASDAQ:LFVN – Get Free Report) last announced its earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. The business had revenue of $47.21 million for the quarter. LifeVantage had a return on equity of 27.85% and a net margin of 1.47%.
LifeVantage Announces Dividend
About LifeVantage
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Read More
- Five stocks we like better than LifeVantage
- Breakout Stocks: What They Are and How to Identify Them
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- 10 Best Airline Stocks to Buy
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.